Autosomal dominant polycystic kidney disease in Colombia.
Chronic kidney failure
Dialysis
Kidney transplant
Polycystic kidney disease
Renal replacement therapy
Journal
BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793
Informations de publication
Date de publication:
17 07 2023
17 07 2023
Historique:
received:
10
01
2023
accepted:
09
07
2023
medline:
19
7
2023
pubmed:
18
7
2023
entrez:
17
7
2023
Statut:
epublish
Résumé
Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic cause of chronic kidney disease (CKD) that requires dialysis. Knowing geographical clusters can be critical for early diagnosis, progression control, and genetic counseling. The objective was to establish the prevalence, geographic location, and ethnic groups of patients with ADPKD who underwent dialysis or kidney transplant in Colombia between 2015 and 2019. We did a cross-sectional study with data from the National Registry of Chronic Kidney Disease (NRCKD) managed by the High-Cost Diseases Fund (Cuenta de Alto Costo [CAC] in Spanish) between July 1, 2015, and June 30, 2019. We included Colombian population with CKD with or without renal replacement therapy (RRT) due to ADPKD. Crude and adjusted prevalence rates were estimated by state and city. 3,339 patients with ADPKD were included, period prevalence was 9.81 per 100,000 population; there were 4.35 cases of RRT per 100,000 population, mean age of 52.58 years (± 13.21), and 52.78% women. Seventy-six patients were Afro-Colombians, six were indigenous, and one Roma people. A total of 46.07% began scheduled dialysis. The highest adjusted prevalence rate was in Valle del Cauca (6.55 cases per 100,000 population), followed by Risaralda, and La Guajira. Regarding cities, Cali had the highest prevalence rate (9.38 cases per 100,000 population), followed by Pasto, Medellin, and Bucaramanga. ADPKD prevalence is lower compared to Europe and US; some states with higher prevalence could be objective to genetic prevalence study.
Sections du résumé
BACKGROUND
Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic cause of chronic kidney disease (CKD) that requires dialysis. Knowing geographical clusters can be critical for early diagnosis, progression control, and genetic counseling. The objective was to establish the prevalence, geographic location, and ethnic groups of patients with ADPKD who underwent dialysis or kidney transplant in Colombia between 2015 and 2019.
METHODS
We did a cross-sectional study with data from the National Registry of Chronic Kidney Disease (NRCKD) managed by the High-Cost Diseases Fund (Cuenta de Alto Costo [CAC] in Spanish) between July 1, 2015, and June 30, 2019. We included Colombian population with CKD with or without renal replacement therapy (RRT) due to ADPKD. Crude and adjusted prevalence rates were estimated by state and city.
RESULTS
3,339 patients with ADPKD were included, period prevalence was 9.81 per 100,000 population; there were 4.35 cases of RRT per 100,000 population, mean age of 52.58 years (± 13.21), and 52.78% women. Seventy-six patients were Afro-Colombians, six were indigenous, and one Roma people. A total of 46.07% began scheduled dialysis. The highest adjusted prevalence rate was in Valle del Cauca (6.55 cases per 100,000 population), followed by Risaralda, and La Guajira. Regarding cities, Cali had the highest prevalence rate (9.38 cases per 100,000 population), followed by Pasto, Medellin, and Bucaramanga.
CONCLUSIONS
ADPKD prevalence is lower compared to Europe and US; some states with higher prevalence could be objective to genetic prevalence study.
Identifiants
pubmed: 37460967
doi: 10.1186/s12882-023-03266-3
pii: 10.1186/s12882-023-03266-3
pmc: PMC10353080
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
211Informations de copyright
© 2023. The Author(s).
Références
Nephrol Dial Transplant. 2014 Sep;29 Suppl 4:iv15-25
pubmed: 25165182
Kidney Int Suppl (2011). 2022 Apr;12(1):7-11
pubmed: 35529086
Lancet. 2015 May 16;385(9981):1993-2002
pubmed: 26090645
Clin Kidney J. 2018 Feb;11(1):62-69
pubmed: 29423204
Kidney360. 2021 Sep 22;2(12):2010-2015
pubmed: 35419536
Sci Rep. 2015 Aug 06;5:12816
pubmed: 26245766
Nephrol Dial Transplant. 2017 Aug 01;32(8):1356-1363
pubmed: 27325254
Nephrol Dial Transplant. 2013 Jun;28(6):1472-87
pubmed: 23300259
Kidney Int. 2015 Jul;88(1):17-27
pubmed: 25786098
BMC Health Serv Res. 2017 Aug 15;17(1):560
pubmed: 28806944
J Bras Nefrol. 2014 Jan-Mar;36(1):18-25
pubmed: 24676610
Nat Rev Nephrol. 2017 Dec;13(12):750-768
pubmed: 28989174
Nefrologia (Engl Ed). 2018 Mar - Apr;38(2):190-196
pubmed: 29471960
PLoS One. 2018 Jan 16;13(1):e0190430
pubmed: 29338003
Nephron Clin Pract. 2011;117(3):c270-5
pubmed: 20847569
Kidney Int. 2013 Sep;84(3):622-3
pubmed: 23989362
Genet Couns. 2012;23(4):435-45
pubmed: 23431742
Am J Kidney Dis. 2016 May;67(5):792-810
pubmed: 26530876
N Engl J Med. 2012 Dec 20;367(25):2407-18
pubmed: 23121377
Am J Kidney Dis. 2014 Oct;64(4):592-9
pubmed: 25134777